Jefferies & Co

Jefferies is out with a research report this morning, which takes a look at the underperformance of the healthcare services names versus their long-term potential. The Jefferies analysts said, “While the broader equity markets performed substantially better last week as investors took advantage of...

Analysts at Jefferies & Co reiterate their "hold" rating on VIVUS Inc (NASDAQ: VVUS). The target price for VVUS is set to $9. According to Jefferies & Co, “A primary argument in favor of Qnexa is the approval of Topamax for migraine prophylaxis, where the topiramate doses are comparable to...

Analysts at Jefferies & Co maintain their "hold" rating on Monsanto (NYSE: MON). The target price for MON is set to $52. Monsanto and BASF announced yesterday the companies would expand their biotechnology research collaboration to include wheat. According to Jefferies & Co, “Initial...

Analysts at Jefferies & Co maintain their "buy" rating on Microsoft (NASDAQ: MSFT), while raising their estimates for the company. The target price for MSFT is set to $36. According to Jefferies & Co, “Since the iPad's debut in April, approximately 3mm iPads have been sold, for a total...

Jefferies & Co. maintained a "hold" rating on State Street (NYSE: STT), but lifted its price target on the custodian bank to $42 to $40 after the company pre-announced bullish second-quarter results. Jefferies also upped its 2Q estimate on State Street to 93 cents a share from 64 cents a share...

Analysts at Jefferies & Co reiterate their "buy" rating on Hologic (NASDAQ: HOLX). The target price for HOLX is set to $20. HOLX is acquiring privately held Sentinelle Medical in a deal amounting to $85 million in cash plus earn-outs. According to Jefferies & Co, “Proposed acquisition...

Jefferies & Co. is out with a research report this morning, where it initiates a Buy rating on shares of Chimera Investment Corp. (NYSE: CIM); it has a $4.25 price target on the stock. The Jefferies analysts said, “In the mortgage REIT space, we view CIM as the most levered name to an...

Analysts at Jefferies & Co reiterate their "hold" rating on Westport Innovations (NASDAQ: WPRT), while reducing their estimates for the company. The target price for WPRT is set to $17. According to Jefferies & Co, “Westport is acquiring 100% of the outstanding shares of OMVL SpA and OMVL's...

Jefferies & Co. is out with a research report this morning, where it reiterates its Hold rating on Intercontinental Exchange (NYSE: ICE); it has a $122.00 price target on the stock. The Jefferies analysts said, “ICE's core futures and options business remains solid. Volumes continue to be...

Analysts at Jefferies & Co maintain their "buy" rating on Boeing (NYSE: BA). The target price for BA is set to $84. According to Jefferies & Co, “The early highlights for June point to higher growth rates than May. The traffic data, according to the Association of European Airlines,...

Jefferies and Company is out with a research report this morning, where it reiterates its Buy rating on shares of Celgene Corp. (NASDAQ: CELG); it has a $63.00 price target on the stock. The Jefferies analysts said, “Expansion of Celgene's hematology footprint into solid tumors makes sense, but...

Jefferies and Company is out with a short research note this morning, which ponders the question of whether Google Inc. (NASDAQ: GOOG) can survive and thrive in China now that they can no longer redirect searches to its Hong Kong operations. The Jefferies analysts said, “Even if Google is able to...

Jefferies and Co. is out with a research report this morning, where it reiterated its Hold rating on shares of Monsanto (NYSE: MON); it has a $52.00 price target on the stock, down from $56.00. The Jefferies analysts said, “Monsanto announced Q3 EPS of $0.81, $0.01 above consensus. Monsanto...

Jefferies and Co. is out with a research report this morning, where it reiterates its Hold rating on shares of Omnova (NYSE: OMN); it has an $8.75 price target on the stock. The Jefferies analysts said, “OMNOVA reported Q2 EPS of $0.27 (adjusted for $0.06 in net one-time items), $0.08 above...